Cybernet Data Systems Inc.
Acadia Pharmaceuticals Reports First Quarter 2023 Financial Results, Reiterates 2023 Guidance
Acadia Pharmaceuticals Inc. announced its financial results for the first quarter of 2023, showcasing strong growth in NUPLAZID sales and a decrease in research and development expenses. The Company's net loss for the quarter decreased to $43.0 million, or $0.27 per common share, compared to a